Antiretroviral treatment uptake and attrition among HIV-positive patients with tuberculosis in Kibera, Kenya.
Tayler-Smith, K;
Zachariah, R;
Manzi, M;
Kizito, W;
Vandenbulcke, A;
Sitienei, J;
Chakaya, J;
Harries, AD;
(2011)
Antiretroviral treatment uptake and attrition among HIV-positive patients with tuberculosis in Kibera, Kenya.
Tropical medicine & international health, 16 (11).
pp. 1380-1383.
ISSN 1360-2276
DOI: https://doi.org/10.1111/j.1365-3156.2011.02863.x
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Using data of human immunodeficiency virus-positive patients with tuberculosis from three primary care clinics in Kibera slums, Nairobi, Kenya, we report on the proportion that started antiretroviral treatment (ART) and attrition (deaths, lost to follow-up and stopped treatment) before and while on ART. Of 427 ART eligible patients, enrolled between January 2004 and December 2008, 70% started ART, 19% were lost to attrition and 11% had not initiated ART. Of those who started ART, 14% were lost to attrition, making a cumulative pre-ART and ART attrition of 33%. ART uptake among patients with TB was relatively good, but programme attrition was high and needs urgent addressing.
